Thousands of men who have experienced prostate cancer are being urged to join a major national study to help develop better screening, tests, and medical care. The initiative, called Prostate Progress, is led by Prostate Cancer Research alongside the NHS DigiTrials team.
Anyone who has received a diagnosis can take part by completing quick, regular surveys and granting researchers secure access to their medical records. Scientists will analyse the information to develop tailored therapies, accelerate diagnoses, and discover new life-saving treatments. The NHS said: "If you have ever had, or are currently living, with prostate cancer, you can sign up to be part of research that will help improve tests, screenings and care."
This drive follows a huge surge in awareness after Olympic cycling legend Sir Chris Hoy publicly shared his own diagnosis. Since coming forward, the 11-time world champion has actively called for better screening measures and earlier health checks.
High-Profile Support
Broadcaster and actor Sir Stephen Fry has also become a leading voice for the cause after undergoing surgery for the disease in 2018. He is currently spearheading recruitment drive efforts for the campaign to encourage widespread participation, writes Rory Poulter on the Mirror.
When launching the initiative last year, Sir Stephen said: "If you've had prostate cancer, joining Prostate Progress is one of the most important things you can do. It takes very little effort, but the information you provide could help save lives for generations to come."
He added that he was delighted to support the scheme, explaining that merging personal accounts with NHS records provides researchers with vital insights. Experts hope this valuable data will significantly improve care standards for future generations.
How the Study Works
Organisers want to involve people from all backgrounds, especially groups that are traditionally under-represented in medical studies. In the UK, around one in eight White men and one in four Black men will face a prostate cancer diagnosis. Enrolled participants will fill out a short online questionnaire every few months. Researchers will securely link those responses to anonymised health records to study treatment journeys and long-term side effects.
Strict safety rules ensure that only verified researchers working on projects for the public benefit can view the data. The ultimate goal is to pinpoint top-performing therapies, upgrade NHS services, and connect suitable candidates with new clinical trials.
Urgent Need for Better Screening
This campaign comes at a crucial moment, as public calls for a national screening system grow stronger. Men aged 50 and above can request a blood test from their GP, but no automatic screening programme exists because current tests are not accurate enough for population-wide use. Campaigners, including Sir Chris Hoy, continue to press for faster progress towards reliable early testing methods.
The NHS has endorsed the initiative via social media, encouraging participation through the official Prostate Progress registration portal. Supported by the NHS DigiTrials team and Prostate Cancer Research, the study aims to enrol thousands of participants to create a comprehensive database that could revolutionise prostate cancer care.
